Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Cross-registry neural domain adaptation to extract mutational test results from pathology reports.

Rios A, Durbin EB, Hands I, Arnold SM, Shah D, Schwartz SM, Goulart BHL, Kavuluru R.

J Biomed Inform. 2019 Sep;97:103267. doi: 10.1016/j.jbi.2019.103267. Epub 2019 Aug 8.

PMID:
31401235
2.

Unlocking the potential of population-based cancer registries.

Tucker TC, Durbin EB, McDowell JK, Huang B.

Cancer. 2019 Nov 1;125(21):3729-3737. doi: 10.1002/cncr.32355. Epub 2019 Aug 5. Review.

3.

Pharmacogenomic potential in advanced cancer patients.

Nichols D, Arnold S, Weiss HL, Wu J, Durbin EB, Miller R, Kolesar J.

Am J Health Syst Pharm. 2019 Mar 19;76(7):415-423. doi: 10.1093/ajhp/zxy079.

PMID:
31361818
4.

Validity of Natural Language Processing for Ascertainment of EGFR and ALK Test Results in SEER Cases of Stage IV Non-Small-Cell Lung Cancer.

Goulart BHL, Silgard ET, Baik CS, Bansal A, Sun Q, Durbin EB, Hands I, Shah D, Arnold SM, Ramsey SD, Kavuluru R, Schwartz SM.

JCO Clin Cancer Inform. 2019 May;3:1-15. doi: 10.1200/CCI.18.00098.

5.

Spatiotemporal Analysis of Lung Cancer Histological Types in Kentucky, 1995-2014.

Christian WJ, Vanderford NL, McDowell J, Huang B, Durbin EB, Absher KJ, Walker CJ, Arnold SM.

Cancer Control. 2019 Jan-Dec;26(1):1073274819845873. doi: 10.1177/1073274819845873.

6.

A case-control study of trace-element status and lung cancer in Appalachian Kentucky.

Unrine JM, Slone SA, Sanderson W, Johnson N, Durbin EB, Shrestha S, Hahn EJ, Feltner F, Huang B, Christian WJ, Mellon I, Orren DK, Arnold SM.

PLoS One. 2019 Feb 27;14(2):e0212340. doi: 10.1371/journal.pone.0212340. eCollection 2019.

7.

Characterization of Squamous Cell Lung Cancers from Appalachian Kentucky.

Liu J, Murali T, Yu T, Liu C, Sivakumaran TA, Moseley HNB, Zhulin IB, Weiss HL, Durbin EB, Ellingson SR, Liu J, Huang B, Hallahan BJ, Horbinski CM, Hodges K, Napier DL, Bocklage T, Mueller J, Vanderford NL, Fardo DW, Wang C, Arnold SM.

Cancer Epidemiol Biomarkers Prev. 2019 Feb;28(2):348-356. doi: 10.1158/1055-9965.EPI-17-0984. Epub 2018 Oct 30.

PMID:
30377206
8.

Global burden of neuroendocrine tumors and changing incidence in Kentucky.

Chauhan A, Yu Q, Ray N, Farooqui Z, Huang B, Durbin EB, Tucker T, Evers M, Arnold S, Anthony LB.

Oncotarget. 2018 Apr 10;9(27):19245-19254. doi: 10.18632/oncotarget.24983. eCollection 2018 Apr 10.

9.

Novel role of prostate apoptosis response-4 tumor suppressor in B-cell chronic lymphocytic leukemia.

McKenna MK, Noothi SK, Alhakeem SS, Oben KZ, Greene JT, Mani R, Perry KL, Collard JP, Rivas JR, Hildebrandt GC, Fleischman RA, Durbin EB, Byrd JC, Wang C, Muthusamy N, Rangnekar VM, Bondada S.

Blood. 2018 Jun 28;131(26):2943-2954. doi: 10.1182/blood-2017-10-813931. Epub 2018 Apr 25.

10.

Effect of complications on oncologic outcomes after pancreaticoduodenectomy for pancreatic cancer.

Le AT, Huang B, Hnoosh D, Saeed H, Dineen SP, Hosein PJ, Durbin EB, Kudrimoti M, McGrath PC, Tzeng CD.

J Surg Res. 2017 Jun 15;214:1-8. doi: 10.1016/j.jss.2017.02.036. Epub 2017 Mar 18.

PMID:
28624029
11.

Incidence of CNS tumors in Appalachian children.

Huang B, Luo A, Durbin EB, Lycan E, Tucker T, Chen Q, Horbinski C, Villano JL.

J Neurooncol. 2017 May;132(3):507-512. doi: 10.1007/s11060-017-2403-2. Epub 2017 Mar 11.

12.

Defining the optimal timing of adjuvant therapy for resected pancreatic adenocarcinoma: A statewide cancer registry analysis.

Saeed H, Hnoosh D, Huang B, Durbin EB, McGrath PC, Desimone P, Maynard E, Anthony LB, Dineen SP, Hosein PJ, Tzeng CW.

J Surg Oncol. 2016 Sep;114(4):451-5. doi: 10.1002/jso.24314. Epub 2016 May 30.

PMID:
27238300
13.

S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide.

Stewart RL, Carpenter BL, West DS, Knifley T, Liu L, Wang C, Weiss HL, Gal TS, Durbin EB, Arnold SM, O'Connor KL, Chen M.

Oncotarget. 2016 Jun 7;7(23):34630-42. doi: 10.18632/oncotarget.8969.

14.

Elevated integrin α6β4 expression is associated with venous invasion and decreased overall survival in non-small cell lung cancer.

Stewart RL, West D, Wang C, Weiss HL, Gal T, Durbin EB, O'Connor W, Chen M, O'Connor KL.

Hum Pathol. 2016 Aug;54:174-83. doi: 10.1016/j.humpath.2016.04.003. Epub 2016 Apr 20.

15.

Nodal Upstaging During Lung Cancer Resection Is Associated With Surgical Approach.

Martin JT, Durbin EB, Chen L, Gal T, Mahan A, Ferraris V, Zwischenberger J.

Ann Thorac Surg. 2016 Jan;101(1):238-44; discussion 44-5. doi: 10.1016/j.athoracsur.2015.05.136. Epub 2015 Sep 28.

16.

Incidence of brain metastasis at initial presentation of lung cancer.

Villano JL, Durbin EB, Normandeau C, Thakkar JP, Moirangthem V, Davis FG.

Neuro Oncol. 2015 Jan;17(1):122-8. doi: 10.1093/neuonc/nou099. Epub 2014 Jun 2.

17.

Predicting the likelihood of an isocitrate dehydrogenase 1 or 2 mutation in diagnoses of infiltrative glioma.

Chen L, Voronovich Z, Clark K, Hands I, Mannas J, Walsh M, Nikiforova MN, Durbin EB, Weiss H, Horbinski C.

Neuro Oncol. 2014 Nov;16(11):1478-83. doi: 10.1093/neuonc/nou097. Epub 2014 May 23.

18.

Automatic Extraction of ICD-O-3 Primary Sites from Cancer Pathology Reports.

Kavuluru R, Hands I, Durbin EB, Witt L.

AMIA Jt Summits Transl Sci Proc. 2013 Mar 18;2013:112-6. eCollection 2013.

19.

Effect of alpha1-adrenoceptor antagonist exposure on prostate cancer incidence: an observational cohort study.

Harris AM, Warner BW, Wilson JM, Becker A, Rowland RG, Conner W, Lane M, Kimbler K, Durbin EB, Baron AT, Kyprianou N.

J Urol. 2007 Nov;178(5):2176-80. Epub 2007 Sep 17.

Supplemental Content

Loading ...
Support Center